Skip to main content
. 2021 Dec 16;12:778204. doi: 10.3389/fimmu.2021.778204

Table 3.

Serum sIFNAR2 levels in MS patients according to IFN beta response.

Responders/Non-responders Basal 6 Months 12 Months
N 22/19 22/19 22/19
25% Percentile 16,52/20,19 18,8/28,99 16,5/23,64
Median 37,61/32,58 35,58/50,6 30,91/33,83
75% Percentile 61,2/42,71 70,38/71,7 59,62/58,72